SEC 13F/TRIMVerified data
ARK Investment Management LLC sold CRSP
13F filer · CRISPR Therapeutics AG · Common Stock
- Side
- SELL
- Δ value
- $101.05M
- Shares
- 1.85M
- Price
- $54.54
- Executed
- Not disclosed
- Disclosed
- Aug 14, 2026
CRSP · daily
Yahoo Finance chart API◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Insider Score
Experimental signal26/ 100 · ROUTINE
Methodology →- Transaction type+6 / 20
TRIM
- Relative size+12 / 25
$101.0M quarter-over-quarter change
- Filing timing0 / 15
Not applicable — 13F reports quarter-end holdings, execution dates are not disclosed
- Historical behavior+8 / 15
First recorded trade by this actor in this security
- Frequency & clustering0 / 15
No clustered activity in the dataset
- Market events0 / 10
No material company filing within 60 days after the trade
Other disclosed activity · CRSP
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Sakhamuri SivakesavaChief Technical Officer | CRSPCRISPR Therapeutics AG Grant or award | A | — 90.0K sh | Nov 6, 2026 |
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Source
- Document
- SEC Form 13F-HR
- Publisher
- U.S. Securities and Exchange Commission (EDGAR)
- Document ID
- 0001104659-26-096910
Timestamps
- Event (reported)
- Not reported
- Published
- Aug 14, 2026
- Ingested by INSIDER
- Nov 4, 22:39 UTC
- Last re-read
- Nov 10, 08:27 UTC
Extracted facts
- Filer
- ARK Investment Management LLC
- Role
- 13F filer
- Transaction
- TRIM
- Asset
- CRISPR Therapeutics AG
- Ticker
- CRSP
- Shares
- 1.85M
- Price per share
- $54.54
- Value
- $101,045,389
- Owned after transaction
- 9.46M shares
What this establishes
ARK Investment Management LLC reported this position change in a quarterly 13F holdings report. 13F shows quarter-end positions only — it does not say when during the quarter shares were bought or sold.
Extraction
- Method
- 13F information table XML
- Confidence
- 1.00
- 13F filer
- ARK Investment Management LLCcik:0001697748
- Issuer
- CRISPR Therapeutics AGcik:0001674416
Revision history · 0
No field has changed since this record was first ingested.